BRCA2 and breast cancer: Given that BRCA1 and BRCA2 were identified more than 20 years ago, preventive mastectomy remains the gold standard, and mutation carriers have strong preferences for chemoprevention, it is timely that an effective breast cancer risk reduction option be identified.